1.1GVBP Receives BUY rating and $1.12 Target Price
Sep 14th, 2009 by beststockreport
Hi everyone,
As promised I am giving you an update on GENova Biotherapeutics tonight.
GVBP has grown a lot the past few weeks as a whole and as a public traded company. It has soared from 0.03 to 0.30 in less than two weeks. That’s a gain of over 1000% in less than 14 days!
GVBP has been announcing a stream of very exciting news from multi-million dollar contracts to billion-dollar revenues. GVBP is following in the footsteps of a few other public companies such as: TTNP, VNDA, CTIC, and HGSI to only name a few… They have all gained over 2000% in a VERY short period of time.
GVBP has just received a BUY recommendation with a $1.12 target price from research firm Grass Roots Research & Distribution. The entire report is available for everyone to look at online: www.grassrootsrd.com/gvbp-report.pdf
GVBP traded a record of over 73,000,000 shares on Friday. This very possibly means that WallStreet has taken notice of the company and is buying a tremendous amount of shares in confidence that GVBP will experience the blockbuster gains that the companies I previously mentioned did.
GVBP gained an average of 25% per day this past week. If it continues climbing as fast, it will close at near a dollar by the end of the week which would be over 300% the current share price.
Take a close look at GVBP as it soars past record highs and makes a lot of you, my subscibers, very wealthy. It is so far my BEST PICK EVER! You can visit GENova’s website at www.genovabio.com and read the Press Releases on yahoo finance or on your favorite finance website.
If you have not picked up GVBP yet, it is definitely not too late. With a target price of over a dollar from renowned analysts now is still an amazing time to BUY.
Happy Trading,
Your CrazyPennyStocks editor.